Mark Aguillard
Corporate Officer/Principal bij DERMTECH, INC.
Vermogen: 52 650 $ op 30-04-2024
Actieve functies van Mark Aguillard
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DERMTECH, INC. | Corporate Officer/Principal | 19-09-2023 | - |
Loopbaan van Mark Aguillard
Eerdere bekende functies van Mark Aguillard
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-07-2021 | 01-09-2023 |
Opleiding van Mark Aguillard
Texas Tech University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DERMTECH, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
- Beurs
- Insiders
- Mark Aguillard
- Ervaring